Home/Filings/4/0001966698-25-000006
4//SEC Filing

Grimaud Brett A. 4

Accession 0001966698-25-000006

CIK 0001583107other

Filed

Nov 23, 7:00 PM ET

Accepted

Nov 24, 6:13 PM ET

Size

4.9 KB

Accession

0001966698-25-000006

Insider Transaction Report

Form 4
Period: 2025-11-20
Grimaud Brett A.
SVP, GEN COUNSEL AND SECRETARY
Transactions
  • Tax Payment

    Ordinary Shares

    2025-11-20$17.90/sh19,024$340,530355,282 total
Footnotes (1)
  • [F1]Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Issuer

Theravance Biopharma, Inc.

CIK 0001583107

Entity typeother

Related Parties

1
  • filerCIK 0001966698

Filing Metadata

Form type
4
Filed
Nov 23, 7:00 PM ET
Accepted
Nov 24, 6:13 PM ET
Size
4.9 KB